Appili Therapeutics Inc (APLIF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Sales | 6 | 258 | 7 | 7 | 4 |
| Gross Profit | 6 | 258 | 7 | 7 | 4 |
| Operating Expenses | 1,660 | 1,921 | 1,787 | 916 | 1,616 |
| Operating Income | -1,653 | -1,664 | -1,780 | -909 | -1,612 |
| Interest Expense | 284 | 339 | 201 | 154 | 136 |
| Other Income | 794 | 23 | 75 | -205 | -64 |
| Pre-tax Income | -1,143 | -1,980 | -1,906 | -1,267 | -1,812 |
| Income Tax | 9 | 6 | 25 | -12 | 8 |
| Net Income Continuous | -1,152 | -1,985 | -1,931 | -1,255 | -1,821 |
| Net Income | $-1,152 | $-1,985 | $-1,931 | $-1,255 | $-1,821 |
| EPS Basic Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Basic Continuous Ops | -0.01 | -0.02 | -0.02 | -0.01 | -0.02 |
| EPS Diluted Total Ops | -0.01 | -0.01 | -0.01 | -0.01 | -0.02 |
| EPS Diluted Continuous Ops | -0.01 | -0.02 | -0.02 | -0.01 | -0.02 |
| EBITDA(a) | $-1,651 | $-1,662 | $-1,780 | $-907 | $-1,611 |